ODTX
Odyssey Therapeutics, Inc.
18.10$
-0.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 24 | Q4 24 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 72.1% | 68.6% | 80.8% | 66.4% | |
| 17.8% | 30.0% | 15.6% | 17.0% | |
| – | – | 76.7% | 64.2% | |
| 6.4% | 6.8% | 6.1% | 2.9% | |
| 0.3% | 0.3% | 0.1% | 0.0% | |
| 257.7% | 293.7% | 328.6% | 12.9% | |
| 11.3% | 14.4% | 9.7% | 5.8% | |
| – | – | 2.3% | 1.1% | |
| 2.4% | 3.2% | 3.6% | 1.6% | |
| -157.7% | -193.7% | -228.6% | 87.1% | |
| -172.7% | -212.5% | -264.7% | -136.2% | |
| 21.3% | 23.9% | 20.6% | 6.3% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.